L’Oréal Is Increasing Stake in Galderma to 20 Percent

Core Insights - L'Oréal has acquired an additional 10 percent stake in Galderma Group AG, increasing its total ownership to 20 percent, emphasizing its commitment to the aesthetics sector [1][2] - The acquisition was made from a consortium led by EQT and is expected to close by the first quarter of 2026 [3] - L'Oréal plans to support Galderma's strategy and independence while exploring synergies between injectable and topical dermatological treatments [4][5] Transaction Details - The transaction will be executed through an off-market block trade, dissolving the previous shareholder agreement with Sunshine SwissCo GmbH [3] - Funding for the acquisition will come from L'Oréal's available cash and credit lines [3] Strategic Intent - L'Oréal views aesthetics as a key area adjacent to its core beauty business and aims to solidify its partnership with Galderma, which has been successful since the initial investment in 2024 [2][4] - The partnership will leverage Galderma's expertise in dermatological solutions and L'Oréal's knowledge in skin biology and diagnostic tools [5] Governance Changes - Following the increased stake, Galderma's board will consider appointing two non-independent board candidates from L'Oréal, replacing the EQT-led consortium starting from the 2026 annual general meeting [6]